NEW YORK CITY, NY / ACCESS Newswire / February 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law ...
Hosted on MSN25d
EMA reviews GSK's new Shingrix syringe for shingles preventionL ONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun reviewing a prefilled syringe form of Shingrix, GSK's vaccine for shingles ...
GlaxoSmithKline Pharmaceuticals shares surged 20% to ₹2,421.30 after a strong Q3FY25 performance, reporting a 400% rise in ...
GSK PLC (NYSE:GSK) reported an 8% increase in sales for 2024, reaching over GBP31 billion, driven by strong growth in specialty medicines. Core operating profit rose by 13% and core EPS increased ...
India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand ...
The company posted a multifold jump per cent in consolidated net profit to Rs 230 crore as compared to Rs 46 crore a year ago ...
Hosted on MSN16d
GSK shares rise over 5% after Q4 resultsLONDON - On Wednesday, GlaxoSmithKline plc (NYSE: NYSE:GSK ... performance was driven by continued growth in its Specialty Medicines segment, which saw sales increase 17% year-over-year to ...
The pharmaceutical company said promising pipeline developments and high demand for drugs in its specialty segment lifted ...
Bengaluru: India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback